Gong acquires Vayo to expand its renowned data analytics capabilities
By Nikita Chaurasia  Date: 2020-09-02

Gong acquires Vayo to expand its renowned data analytics capabilities

American revenue intelligence platform Gong.io has recently announced the acquisition of Israeli-based data analytics start up Vayo. As per the agreement, Vayo’s team will become a part of Gong and to expand its data analytics capabilities.

The announcement comes along the heels of Gong’s successful USD 200 million Series D funding round, which allowed the company to reach a valuation of USD 2.2 billion.

For those unfamiliar, the revenue intelligence platform of Gong helps in improving CRM (customer relationship management) remotely. The platform precisely records the various interactions between customers and sales organization, and the company then offers AI-based insights from the acquired data.

Amit Bendov, Gong’s CEO was reported saying that the acquisition will allow over 70% of its customers to close deals faster. He added that integrating Vayo’s technology in Gong’s business model will help in developing innovative solutions for sales professionals across various industry verticals.

Vayo’s CEO Avshi Avital mentioned in a comment that the company is thrilled to join hands with the U.S. -based company, since it is a market leader in revenue intelligence platform. The CEO further claimed that the two companies always intended to revolutionize artificial intelligence in sales industry, and the recent acquisition will allow Gong’s customers to avail benefits from Vayo’s technology.

If sources are to be believed, Gong had initially introduced a Deal Intelligence platform in March 2020, which offers up-to-date and accurate insights of all the deals conducted in a sales organization. The technology reportedly allows sales professionals to focus on recognizing at-risk deals and accordingly strategize around them.

The terms of the recent acquisition were not disclosed, stated sources aware of the development.

About Vayo

Since its inception in 2018, Vayo specializes in developing software that measures cross-platform and complex data from customer interactions and subsequently recognizes common and crucial themes that can help in enhancing the performance of sales teams as well as organizations.

Source Credits –

https://www.gong.io/press/gong-acquires-vayo-to-enhance-its-revenue-intelligence-platform/

About Author

Nikita Chaurasia    

Nikita Chaurasia

An accomplished professional in the field of content development, playing with words comes naturally to Nikita Chaurasia. After completing her post-graduate MBA degree in Advertising and PR, Nikita worked across numerous content-driven verticals, undertaking diverse r...

Read More

More News By Nikita Chaurasia

Fragomen acquires SimpleCitizen to reinforce its immigration services
Fragomen acquires SimpleCitizen to reinforce its immigration services
By Nikita Chaurasia

In a recent turn of events, Fragomen, Del Rey, Bernsen & Loewy, LLP, a leading corporate immigration law company has reportedly joined hands with SimpleCitizen Inc. to form Fragomen Technologies Inc., a new subsidiary which will provide a combina...

Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
Nautilus buys 17 MW portfolio from solar energy developer Pine Gate
By Nikita Chaurasia

Solar project development and asset management major, Nautilus Solar Energy LLC, has reportedly announced its acquisition of two solar portfolios in Rhode Island and Oregon amounting to a total of nearly 17 MW from leading solar energy developer, Pin...

Locate Bio obtains multiple late stage orthobiologics assets from RCSI
Locate Bio obtains multiple late stage orthobiologics assets from RCSI
By Nikita Chaurasia

Regenerative medicine major, Locate Bio, has reportedly announced its in-licensing of several late stage orthobiologics assets from the RCSI University of Medicine and Health Sciences. Sources state that the technologies created by the RCSI Tissue E...

Roche acquires Inflazome to gain control over inflammatory treatments
Roche acquires Inflazome to gain control over inflammatory treatments
By Nikita Chaurasia

In a recent turn of events, Swiss healthcare giant, F. Hoffmann-La Roche AG has reportedly acquired an Irish biotech firm Inflazome Ltd. for approximately USD 451 million (€380 million). As per the agreement, Roche will acquire complete rights ...

Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
Innovent, Eli Lilly release results of ORIENT-11 trial for lung cancer
By Nikita Chaurasia

Innovent Biologics Inc., in collaboration with American pharmaceutical giant Eli Lilly and Company, have reportedly announced that the biomarker results of ORIENT-11 trials which were displayed during a mini verbal presentation at ESMO (European Soci...